 Doctor Tipster | Resisting Cancer's Resistance dailyRx Adding a second class of drugs called mTOR inhibitors boosts the effectiveness of a targeted therapy - Xalkori (crizotinib) - in children with neuroblastoma. Talk to your oncologist about combination therapies. Researchers at The Institute of Cancer ... Scientists develop new strategy to overcome drug-resistant childhood cancer New Study Manages To Prevent Neuroblastoma Resistance To Crizotinib |
